nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—GHRHR—brain—conduct disorder	0.0503	0.137	CbGeAlD
Docetaxel—MAP2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0451	0.0712	CbGpPWpGaD
Docetaxel—KIF11—brain—conduct disorder	0.0428	0.116	CbGeAlD
Docetaxel—GHRHR—G alpha (s) signalling events—CGA—conduct disorder	0.0353	0.0558	CbGpPWpGaD
Docetaxel—TUBB8—brain—conduct disorder	0.0289	0.0786	CbGeAlD
Docetaxel—GHRHR—GPCRs, Other—DRD4—conduct disorder	0.0253	0.04	CbGpPWpGaD
Docetaxel—MAPT—brain—conduct disorder	0.0251	0.0682	CbGeAlD
Docetaxel—TUBB3—brain—conduct disorder	0.0197	0.0536	CbGeAlD
Docetaxel—MAP4—brain—conduct disorder	0.0197	0.0536	CbGeAlD
Docetaxel—TUBB1—brain—conduct disorder	0.0193	0.0524	CbGeAlD
Docetaxel—BCL2—brain—conduct disorder	0.0179	0.0488	CbGeAlD
Docetaxel—EGFR—brain—conduct disorder	0.0177	0.0482	CbGeAlD
Docetaxel—GHRHR—GPCRs, Other—HTR2A—conduct disorder	0.0165	0.0261	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0156	0.0246	CbGpPWpGaD
Docetaxel—MAP2—brain—conduct disorder	0.0155	0.0422	CbGeAlD
Docetaxel—TUBB2B—Orphan transporters—GABRA2—conduct disorder	0.0153	0.0242	CbGpPWpGaD
Docetaxel—TUBB6—Orphan transporters—GABRA2—conduct disorder	0.0153	0.0242	CbGpPWpGaD
Docetaxel—TUBB3—Orphan transporters—GABRA2—conduct disorder	0.0148	0.0234	CbGpPWpGaD
Docetaxel—TUBB2A—Orphan transporters—GABRA2—conduct disorder	0.0143	0.0226	CbGpPWpGaD
Docetaxel—TUBB1—Orphan transporters—GABRA2—conduct disorder	0.014	0.0221	CbGpPWpGaD
Docetaxel—CYP1B1—Estrogen metabolism—COMT—conduct disorder	0.0139	0.022	CbGpPWpGaD
Docetaxel—SLC22A7—brain—conduct disorder	0.0134	0.0365	CbGeAlD
Docetaxel—GHRHR—GPCR ligand binding—CGA—conduct disorder	0.0128	0.0202	CbGpPWpGaD
Docetaxel—TUBB4A—Orphan transporters—GABRA2—conduct disorder	0.0126	0.0199	CbGpPWpGaD
Docetaxel—TUBB4A—brain—conduct disorder	0.012	0.0326	CbGeAlD
Docetaxel—MAP2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0117	0.0185	CbGpPWpGaD
Docetaxel—TUBB2B—brain—conduct disorder	0.0116	0.0315	CbGeAlD
Docetaxel—TUBB4B—Orphan transporters—GABRA2—conduct disorder	0.0115	0.0182	CbGpPWpGaD
Docetaxel—TUBB—brain—conduct disorder	0.011	0.0298	CbGeAlD
Docetaxel—TUBB2A—brain—conduct disorder	0.0109	0.0297	CbGeAlD
Docetaxel—TUBB6—brain—conduct disorder	0.0108	0.0293	CbGeAlD
Docetaxel—MAP2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00956	0.0151	CbGpPWpGaD
Docetaxel—CYP1B1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00942	0.0149	CbGpPWpGaD
Docetaxel—ABCC10—brain—conduct disorder	0.00942	0.0256	CbGeAlD
Docetaxel—TUBB4B—brain—conduct disorder	0.00935	0.0255	CbGeAlD
Docetaxel—KIF11—Immune System—MB21D1—conduct disorder	0.00916	0.0145	CbGpPWpGaD
Docetaxel—KIF11—Factors involved in megakaryocyte development and platelet production—EP300—conduct disorder	0.00746	0.0118	CbGpPWpGaD
Docetaxel—CYP1B1—brain—conduct disorder	0.00741	0.0202	CbGeAlD
Docetaxel—GHRHR—GPCR downstream signaling—CGA—conduct disorder	0.00724	0.0114	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—DRD4—conduct disorder	0.00717	0.0113	CbGpPWpGaD
Docetaxel—KIF11—Immune System—POLR3A—conduct disorder	0.00672	0.0106	CbGpPWpGaD
Docetaxel—ABCC1—brain—conduct disorder	0.00666	0.0181	CbGeAlD
Docetaxel—GHRHR—Signaling by GPCR—CGA—conduct disorder	0.00657	0.0104	CbGpPWpGaD
Docetaxel—TUBB2A—Signaling events mediated by HDAC Class III—EP300—conduct disorder	0.00647	0.0102	CbGpPWpGaD
Docetaxel—MAPT—Kit receptor signaling pathway—EP300—conduct disorder	0.00618	0.00977	CbGpPWpGaD
Docetaxel—MAPT—Notch Signaling Pathway—EP300—conduct disorder	0.00602	0.00951	CbGpPWpGaD
Docetaxel—ABCC10—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0059	0.00933	CbGpPWpGaD
Docetaxel—KIF11—Immune System—WASF1—conduct disorder	0.00566	0.00895	CbGpPWpGaD
Docetaxel—ABCG2—brain—conduct disorder	0.00552	0.015	CbGeAlD
Docetaxel—MAP2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00507	0.00801	CbGpPWpGaD
Docetaxel—GHRHR—GPCR ligand binding—HTR2A—conduct disorder	0.00468	0.0074	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.00443	0.00701	CbGpPWpGaD
Docetaxel—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00427	0.00675	CbGpPWpGaD
Docetaxel—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00421	0.00666	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MB21D1—conduct disorder	0.00411	0.0065	CbGpPWpGaD
Docetaxel—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00408	0.00645	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—DRD4—conduct disorder	0.00405	0.00641	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CGA—conduct disorder	0.00388	0.00614	CbGpPWpGaD
Docetaxel—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00385	0.00609	CbGpPWpGaD
Docetaxel—BCL2—Kit receptor signaling pathway—EP300—conduct disorder	0.0038	0.00601	CbGpPWpGaD
Docetaxel—BCL2—ATF-2 transcription factor network—EP300—conduct disorder	0.0038	0.00601	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00373	0.0059	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00373	0.0059	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—DRD4—conduct disorder	0.00368	0.00582	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CGA—conduct disorder	0.00362	0.00572	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CGA—conduct disorder	0.00362	0.00572	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00361	0.0057	CbGpPWpGaD
Docetaxel—BCL2—Validated targets of C-MYC transcriptional repression—EP300—conduct disorder	0.00361	0.0057	CbGpPWpGaD
Docetaxel—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.0036	0.00568	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CGA—conduct disorder	0.00349	0.00553	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00349	0.00552	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00342	0.0054	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CGA—conduct disorder	0.00338	0.00535	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CGA—conduct disorder	0.00331	0.00523	CbGpPWpGaD
Docetaxel—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00326	0.00515	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—WASF1—conduct disorder	0.00311	0.00492	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00307	0.00485	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—POLR3A—conduct disorder	0.00302	0.00477	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CGA—conduct disorder	0.00297	0.0047	CbGpPWpGaD
Docetaxel—TUBB—G2/M Transition—EP300—conduct disorder	0.00293	0.00463	CbGpPWpGaD
Docetaxel—TUBB—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00289	0.00456	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—EP300—conduct disorder	0.00286	0.00453	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00284	0.00449	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00281	0.00445	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00281	0.00445	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00281	0.00443	CbGpPWpGaD
Docetaxel—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00278	0.0044	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—POLR3A—conduct disorder	0.00278	0.00439	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00274	0.00433	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00274	0.00433	CbGpPWpGaD
Docetaxel—ABCB1—brain—conduct disorder	0.00272	0.0074	CbGeAlD
Docetaxel—TUBB4B—Metabolism of proteins—CGA—conduct disorder	0.00272	0.0043	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00267	0.00422	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—HTR2A—conduct disorder	0.00264	0.00418	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—EP300—conduct disorder	0.00261	0.00412	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—WASF1—conduct disorder	0.00254	0.00401	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00253	0.00401	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MB21D1—conduct disorder	0.00243	0.00384	CbGpPWpGaD
Docetaxel—TUBB4A—G2/M Transition—EP300—conduct disorder	0.00243	0.00384	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00241	0.00382	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HTR2A—conduct disorder	0.0024	0.0038	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MB21D1—conduct disorder	0.00239	0.00378	CbGpPWpGaD
Docetaxel—TUBB4A—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00239	0.00378	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00228	0.00361	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00227	0.00359	CbGpPWpGaD
Docetaxel—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.00225	0.00356	CbGpPWpGaD
Docetaxel—TUBB4B—G2/M Transition—EP300—conduct disorder	0.00222	0.00351	CbGpPWpGaD
Docetaxel—TUBB4B—Mitotic G2-G2/M phases—EP300—conduct disorder	0.00219	0.00346	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—DRD4—conduct disorder	0.00217	0.00344	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00206	0.00326	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00205	0.00323	CbGpPWpGaD
Docetaxel—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00203	0.00321	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00201	0.00318	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00194	0.00307	CbGpPWpGaD
Docetaxel—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00192	0.00303	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—EP300—conduct disorder	0.0019	0.00301	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00181	0.00287	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00179	0.00283	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00179	0.00283	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—POLR3A—conduct disorder	0.00178	0.00282	CbGpPWpGaD
Docetaxel—BCL2—Immune System—POLR3A—conduct disorder	0.00176	0.00278	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00173	0.00273	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—EP300—conduct disorder	0.00162	0.00256	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00158	0.00249	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00151	0.00238	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—WASF1—conduct disorder	0.0015	0.00237	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00149	0.00235	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00148	0.00235	CbGpPWpGaD
Docetaxel—BCL2—Immune System—WASF1—conduct disorder	0.00148	0.00234	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00148	0.00234	CbGpPWpGaD
Docetaxel—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00147	0.00232	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HTR2A—conduct disorder	0.00142	0.00224	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MB21D1—conduct disorder	0.00141	0.00224	CbGpPWpGaD
Docetaxel—KIF11—Immune System—EP300—conduct disorder	0.00137	0.00216	CbGpPWpGaD
Docetaxel—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00129	0.00205	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CGA—conduct disorder	0.00127	0.002	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CGA—conduct disorder	0.00119	0.00189	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—EP300—conduct disorder	0.00113	0.00178	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00106	0.00167	CbGpPWpGaD
Docetaxel—EGFR—Immune System—POLR3A—conduct disorder	0.00104	0.00164	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00104	0.00164	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—EP300—conduct disorder	0.000931	0.00147	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CGA—conduct disorder	0.000895	0.00141	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000878	0.00139	CbGpPWpGaD
Docetaxel—EGFR—Immune System—WASF1—conduct disorder	0.000874	0.00138	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CGA—conduct disorder	0.000865	0.00137	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000852	0.00135	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—EP300—conduct disorder	0.000833	0.00132	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CGA—conduct disorder	0.000787	0.00124	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CGA—conduct disorder	0.00078	0.00123	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—EP300—conduct disorder	0.000772	0.00122	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EP300—conduct disorder	0.000752	0.00119	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—EP300—conduct disorder	0.000706	0.00112	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CGA—conduct disorder	0.000705	0.00111	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000692	0.00109	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—EP300—conduct disorder	0.00069	0.00109	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000687	0.00109	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000683	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—DRD4—conduct disorder	0.000669	0.00106	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—EP300—conduct disorder	0.000631	0.000998	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EP300—conduct disorder	0.000613	0.000969	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—COMT—conduct disorder	0.000571	0.000903	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—MAOA—conduct disorder	0.000567	0.000897	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—WASF1—conduct disorder	0.000565	0.000893	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CGA—conduct disorder	0.000564	0.000892	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00055	0.00087	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000443	0.000701	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HTR2A—conduct disorder	0.000436	0.00069	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CGA—conduct disorder	0.000426	0.000673	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—EP300—conduct disorder	0.00041	0.000649	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—COMT—conduct disorder	0.000404	0.000639	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MAOA—conduct disorder	0.000401	0.000634	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DRD4—conduct disorder	0.000395	0.000624	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—COMT—conduct disorder	0.000391	0.000618	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000389	0.000615	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MAOA—conduct disorder	0.000388	0.000613	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000376	0.000595	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—EP300—conduct disorder	0.000363	0.000573	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EP300—conduct disorder	0.000357	0.000565	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—COMT—conduct disorder	0.000355	0.000562	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MAOA—conduct disorder	0.000353	0.000558	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—COMT—conduct disorder	0.000352	0.000557	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MAOA—conduct disorder	0.00035	0.000553	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CGA—conduct disorder	0.000262	0.000415	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR2A—conduct disorder	0.000258	0.000407	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—COMT—conduct disorder	0.000255	0.000403	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MAOA—conduct disorder	0.000253	0.0004	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—conduct disorder	0.000245	0.000387	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—conduct disorder	0.000211	0.000334	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—conduct disorder	0.000207	0.000327	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—conduct disorder	0.000195	0.000308	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—COMT—conduct disorder	0.000192	0.000304	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MAOA—conduct disorder	0.000191	0.000302	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—conduct disorder	0.000173	0.000274	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—conduct disorder	0.000168	0.000265	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—conduct disorder	0.000152	0.000241	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—conduct disorder	0.000151	0.000239	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—conduct disorder	0.000137	0.000216	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—COMT—conduct disorder	0.000118	0.000187	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MAOA—conduct disorder	0.000118	0.000186	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—conduct disorder	0.000109	0.000173	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—conduct disorder	8.24e-05	0.00013	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—conduct disorder	5.08e-05	8.03e-05	CbGpPWpGaD
